125(top 100%)
publications
3.6K
citations
34(top 20%)
h-index
0.06(top 100%)
e-Score
2.5(top 20%)
2-year impact

Key facts

Current Drug Targets Cardiovascular & Haematological Disorders has 125 publications and 3,614 citations in exaly, which is 28.9 citations per publication. Its h-index is 34 (2026), in the top 20% of journals that year. Its Score D is 0.06 (2007), in the top 100% of journals that year. Its 2-year impact is 2.53 (2007), in the top 20% of journals that year. Its 5-year impact is 1.94 (2010), in the top 20% of journals that year. Its 10-year impact is 0.94 (2015), in the top 50% of journals that year. Patents cite this work 29 times. Data version: 2026-11-10.

Current Drug Targets Cardiovascular & Haematological Disorders 2-Year Impact
This chart shows the 2-Year Impact of Current Drug Targets Cardiovascular & Haematological Disorders over time and its percentile among journals.
Current Drug Targets Cardiovascular & Haematological Disorders: percentile record by year
Each cell is the percentile of Current Drug Targets Cardiovascular & Haematological Disorders among all journals in that year: 99 means higher than 99% of them, and darker is higher. Blank means no ranked value that year. Publications, citations and h-index grow with size.
Download data:JSONCSV

How influential is Current Drug Targets Cardiovascular & Haematological Disorders in terms of citations?

Based on the citation analysis of 125 articles Current Drug Targets Cardiovascular & Haematological Disorders has published so far, 2% of its articles have received no citation at all. 3 articles (about 2% of the total articles) have received only one citation. 14.40% of the articles (6) have received over 100 citations.
How to cite this page

exaly, “Current Drug Targets Cardiovascular & Haematological Disorders”, data version 2026-11-10, https://exaly.com/journal/37094/current-drug-targets-cardiovascular-haematological-disorders, licensed under CC BY-SA 4.0.